LABP
Landos Biopharma Inc
Price:  
22.93 
USD
Volume:  
50,899.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LABP WACC - Weighted Average Cost of Capital

The WACC of Landos Biopharma Inc (LABP) is 6.5%.

The Cost of Equity of Landos Biopharma Inc (LABP) is 9.20%.
The Cost of Debt of Landos Biopharma Inc (LABP) is 5.00%.

Range Selected
Cost of equity 7.10% - 11.30% 9.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.4% - 7.5% 6.5%
WACC

LABP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.71 1.16
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 11.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.4% 7.5%
Selected WACC 6.5%